Presentation Information

Sponsored Seminar

 

[ILS-FR-17] Lunch Seminar 17: Ranibizumab: transformational outcomes in patients with DME and RVO
Go back
Day
Apr 04 (Fri)
Time
12:15 - 13:15
Room
Room 2 - Tokyo International Forum 4,5F Hall C
Sponsor
Novartis Pharma AG
Topic
Retina, Vitreous body
Chair/Coordinator
Chair)Yuichiro Ogura、Chair)José Cunha-Vaz
 
 
print

ILS-FR-17

Evidence for individualized dosing: insights from recent anti-VEGF clinical trials

【Speaker】
Christian Prünte


No abstract

Go back